Amy Butler - Northpointe Bancshares Executive Sales
| NPB Stock | 17.30 0.10 0.57% |
Executive
Amy Butler is Executive Sales of Northpointe Bancshares
| Age | 49 |
| Address | 3333 Deposit Drive Northeast, Grand Rapids, MI, United States, 49546-1467 |
| Phone | 616 940 9400 |
| Web | https://www.northpointe.com |
Northpointe Bancshares Management Efficiency
The company has Return on Asset of 0.0116 % which means that on every $100 spent on assets, it made $0.0116 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1312 %, implying that it generated $0.1312 on every 100 dollars invested. Northpointe Bancshares' management efficiency ratios could be used to measure how well Northpointe Bancshares manages its routine affairs as well as how well it operates its assets and liabilities. As of January 11, 2026, Return On Tangible Assets is expected to decline to -0.1. In addition to that, Return On Capital Employed is expected to decline to -0.24. At present, Northpointe Bancshares' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 19.5 M, whereas Non Current Assets Total are forecasted to decline to about 278.5 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Nicholas Smith | Cullinan Oncology LLC | N/A | |
| Yajing Chen | Zai Lab | 58 | |
| MS CPA | Erasca Inc | 59 | |
| Shu Wu | Legend Biotech Corp | N/A | |
| James JD | Legend Biotech Corp | N/A | |
| Yuhong Qiu | Legend Biotech Corp | N/A | |
| Mayra ReyesArmour | C4 Therapeutics | N/A | |
| Michael Varney | Erasca Inc | 67 | |
| JD Esq | Erasca Inc | 54 | |
| Mr MBA | C4 Therapeutics | 46 | |
| Dawei Xuan | Erasca Inc | N/A | |
| Mythili MD | Legend Biotech Corp | 46 | |
| Amy Parker | Erasca Inc | N/A | |
| Harish CFA | Alx Oncology Holdings | 45 | |
| Shelly Pinto | Alx Oncology Holdings | 47 | |
| Kendra Adams | C4 Therapeutics | N/A | |
| Kevin Johnston | Cullinan Oncology LLC | N/A | |
| Tina Carter | Legend Biotech Corp | N/A | |
| Birk Vanderweeen | Legend Biotech Corp | N/A | |
| Esq JD | Erasca Inc | 52 | |
| Shan He | Zai Lab | N/A | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0116 |
Northpointe Bancshares Leadership Team
Elected by the shareholders, the Northpointe Bancshares' board of directors comprises two types of representatives: Northpointe Bancshares inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Northpointe. The board's role is to monitor Northpointe Bancshares' management team and ensure that shareholders' interests are well served. Northpointe Bancshares' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Northpointe Bancshares' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charles Williams, Chairman Founder | ||
| Bradley Howes, Executive CFO | ||
| Kevin Comps, President Secretary | ||
| David Christel, President Program | ||
| Gary Dykstra, Senior Controller | ||
| Patrick Collins, Senior Lending | ||
| Amy Butler, Executive Sales |
Northpointe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Northpointe Bancshares a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0116 | ||||
| Profit Margin | 0.33 % | ||||
| Operating Margin | 0.46 % | ||||
| Current Valuation | 1.57 B | ||||
| Shares Outstanding | 34.36 M | ||||
| Shares Owned By Insiders | 32.13 % | ||||
| Shares Owned By Institutions | 50.58 % | ||||
| Number Of Shares Shorted | 320.03 K | ||||
| Price To Book | 0.95 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Northpointe Bancshares offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Northpointe Bancshares' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Northpointe Bancshares Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Northpointe Bancshares Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Northpointe Bancshares. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. For information on how to trade Northpointe Stock refer to our How to Trade Northpointe Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Regional Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Northpointe Bancshares. If investors know Northpointe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Northpointe Bancshares listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Earnings Share 1.81 | Revenue Per Share | Quarterly Revenue Growth 0.177 | Return On Assets |
The market value of Northpointe Bancshares is measured differently than its book value, which is the value of Northpointe that is recorded on the company's balance sheet. Investors also form their own opinion of Northpointe Bancshares' value that differs from its market value or its book value, called intrinsic value, which is Northpointe Bancshares' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Northpointe Bancshares' market value can be influenced by many factors that don't directly affect Northpointe Bancshares' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Northpointe Bancshares' value and its price as these two are different measures arrived at by different means. Investors typically determine if Northpointe Bancshares is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Northpointe Bancshares' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.